The NDA submission is backed by results from a study that enrolled 604 adults from China who have stable plaque psoriasis.

Plaque psoriasis, the most common form of psoriasis (about 90 per cent of cases), is a chronic inflammatory autoimmune ...

For plaque or guttate psoriasis, home-based narrowband ultraviolet B phototherapy is as effective as office-based ...

LEO Pharma A/S, a global leader in medical dermatology, has today announced its submission of a New Drug Application (NDA) to ...

Does your hair's length affect how you take care of, maintain, and stop scalp psoriasis from returning? Let's talk about it.

Zasocitinib demonstrates effectiveness and safety in the treatment of moderate to severe plaque psoriasis, according to study results published in JAMA Dermatology ... [Z]asocitinib…achieved ...

Many patients struggle with therapeutic control, adverse effects, and costs of psoriasis treatments, prompting a renewed ...

“LEO Pharma strives to enhance patient care and elevate quality of life for those living with complex skin conditions like plaque psoriasis,” said Byron Yin, General Manager for LEO ...

The FDA has already approved Zoryve cream (0.3% and 0.15%) for plaque psoriasis and atopic dermatitis in adults and children ...